Shortened radiation therapy offers similar quality of life for low-risk prostate cancer patients : medicalxpress

as informed in medicalxpress

Shortened radiation therapy offers similar quality of life for low-risk prostate cancer patients

Shortened radiation therapy offers similar quality of life for low-risk prostate cancer patients

Low-risk prostate cancer patients may be able to undergo a shortened course of radiation therapy that cuts treatment by weeks and offers comparable outcomes and quality of life results as those who undergo longer treatment courses, according to new study.Patient's quality of life – which includes bowel and urinary function, and sexual health – was essentially the same for low-risk prostate cancer patients a year after being treated with hypofractionated, or abbreviated external beam, radiation therapy compared to tradition radiation therapy."This study is very important as we're continuously looking for ways to offer cancer patients care that's more convenient and value-based" says study senior author Benjamin Movsas, M.D., chair of the Department of Radiation Oncology at Henry Ford Hospital.


moreover from medicalxpress

Radiation therapy and radical prostatectomy further explored for initial diagnosis of advanced prostate cancer

Radiation therapy and radical prostatectomy further explored for initial diagnosis of advanced prostate cancer

A database study examining surgical removal of the prostate gland (radical prostatectomy) or a form of radiation therapy known as IMRT to treat prostate cancer that has spread to other parts of the body (metastatic) shows an association between each of these treatments and improved overall survival.The work is being presented at the 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) in Boston this week."While numerous treatment options exist for those with early stage prostate cancer, therapies are more limited for those with advanced disease that has spread beyond the prostate," notes the work's senior investigator, Rutgers Cancer Institute radiation oncologist Rahul R. Parikh, MD, who is the co-director of proton beam therapy at Rutgers Cancer Institute of New Jersey and its flagship hospital Robert Wood Johnson University Hospital (RWJ).


by the same token on dotmed

Toxicity results using extremely hypofractionated radiation therapy for prostate cancer are promising: ASTRO

Toxicity results using extremely hypofractionated radiation therapy for prostate cancer are promising: ASTRO

Story Continues Below AdvertisementAd Statistics Times Displayed: 1023834Times Visited: 5649 New & Refurbished C-Arm Systems.Call 702.384.0085 Today!KenQuest provides all major brands of surgical c-arms (new and refurbished) and carries a large inventory for purchase or rent.